[Mutant-prevention concentration: a new, clinically relevant parameter of antimicrobial activity?].
Cantón
Rafael
R
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects / Q000235:genetics; D004305:Dose-Response Relationship, Drug; D024881:Drug Resistance, Bacterial / Q000235:genetics; D024841:Fluoroquinolones / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D005798:Genes, Bacterial / Q000187:drug effects; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000592:standards*; D009152:Mutagenicity Tests; D009154:Mutation / Q000187:drug effects*; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones